Possible Vaccine Risk For Those Highly Allergic

Bloom

A clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are at increased risk for an immediate, systemic allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines. A systemic allergic reaction to a vaccine occurs in one or more parts of the body beyond the injection site.

Dr. Thomas Casale, a professor of medicine at the USF Health Morsani College of Medicine, who has been selected to serve as chief medical advisor for operations for the Food Allergy Research & Education.. the largest private funding of food allergy research in the world, joins Gayle Guyardo on BLOOM with more on the ongoing research.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

get the app

News App

Weather App

Don't Miss

More Don't Miss